InvestorsHub Logo
Followers 11
Posts 975
Boards Moderated 0
Alias Born 05/25/2012

Re: Rymankoly post# 2382

Saturday, 10/05/2013 8:00:36 PM

Saturday, October 05, 2013 8:00:36 PM

Post# of 4817
ANIP owns no more than BPAX and that was only the north american rights. Plus, ANIP has gone on record stating they have no interest in pursuing Libigel. I'm sure Pfyser could easily buy back ANIP's rights. I'm not trying to be contrary but both Pfyser and Antares have mor to gain from a Libigel offshoot than from any other drug.